8.53
Nutriband Inc stock is traded at $8.53, with a volume of 56,432.
It is down -3.18% in the last 24 hours and up +10.78% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$8.81
Open:
$8.97
24h Volume:
56,432
Relative Volume:
0.65
Market Cap:
$95.15M
Revenue:
$2.09M
Net Income/Loss:
$-5.28M
P/E Ratio:
-12.73
EPS:
-0.67
Net Cash Flow:
$-3.64M
1W Performance:
+5.18%
1M Performance:
+10.78%
6M Performance:
+0.00%
1Y Performance:
+0.71%
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Compare NTRB with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NTRB
Nutriband Inc
|
8.53 | 98.06M | 2.09M | -5.28M | -3.64M | -0.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-22-25 | Initiated | Noble Capital Markets | Outperform |
Nutriband Inc Stock (NTRB) Latest News
Will Nutriband Inc. stock split in the near futureDynamic capital growth - jammulinksnews.com
What analysts say about Nutriband Inc. stockExceptional risk-adjusted gains - PrintWeekIndia
Nutriband Inc. Equity Warrant Stock Analysis and ForecastExceptional profit velocity - PrintWeekIndia
Nutriband Inc. Stock Analysis and ForecastTremendous growth opportunities - PrintWeekIndia
What drives Nutriband Inc. Equity Warrant stock priceExceptional trading performance - PrintWeekIndia
What analysts say about Nutriband Inc. Equity Warrant stockExplosive earnings growth - Autocar Professional
What drives Nutriband Inc. stock priceHigh-velocity capital appreciation - Autocar Professional
Is Nutriband Inc. Equity Warrant a good long term investmentExceptional gains - jammulinksnews.com
Is Nutriband Inc. a good long term investmentExtraordinary profit generation - jammulinksnews.com
(NTRB) Investment Analysis - news.stocktradersdaily.com
What makes Nutriband Inc. stock price move sharplyFree Stock Selection with 300% Return - Newser
Why Nutriband Inc. stock attracts strong analyst attentionFree Stock Market Swing Trading Strategies - Newser
Nutriband (NASDAQ: NTRB) Sets Key Dates For 25% Preferred Stock Dividend - Barchart.com
Nutriband (NASDAQ: NTRB) Sets Key Dates for 25% Preferred Stock Dividend - The Globe and Mail
Nutriband announces key dates for 25% preferred stock dividend By Investing.com - Investing.com Nigeria
Nutriband announces key dates for 25% preferred stock dividend - Investing.com
Nutriband Inc. Announces Key Dates for Upcoming 25% Preferred Stock Dividend - Quiver Quantitative
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval - GlobeNewswire
Nutriband Sets 25% Preferred Stock Dividend Record Date, Links to Future FDA Approval Benefits - Stock Titan
why nutriband inc. equity warrant stock attracts strong analyst attentionFree Stock Market Query - Newser
NutriBand authorizes new Series A preferred stock and announces dividend - Investing.com Australia
NutriBand authorizes new Series A preferred stock and announces dividend By Investing.com - Investing.com Nigeria
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):